focus -WSS

focus

author：hotspot 2025-09-30 08:27:05 - browse：357

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Why patients can’t get everything they want on drug pricing

explore

WSS

Meta's Zuckerberg and Chan on track to put $50 billion into science

STAT Report: Patient voices and perspectives

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

New Alzheimer's drugs heat up race for early detection blood tests

Cassava reveals details — and problems — with Alzheimer's study

The pink breast cancer awareness ribbon needs a redesign

focus

focus

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Dems pitch expanding Medicare power to negotiate drug prices

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

New air purifier tech could be key to improving indoor air quality

New lawsuit accuses health insurer Cigna of denying claims in bulk

Drug repurposing or repositioning? The language matters

Roche’s Alnylam deal shows drug firms interested in heart drugs

What does generative AI mean for health care? We asked experts

STAT Report: Patient voices and perspectives

leisure time

Rise in cancer among younger people worries and puzzles doctors

Readout Newsletter: XBI biotech index, Akero Therapeutics

The FDA weighs the risks of candy

The FDA weighs the risks of candy

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

The haunting brain science of long Covid

hotspot

explore

explore

hotspot